REFERENCES
- Chui DHK, Waye JS. Hydrops fetalis caused by α-thalassemia: an emerging health care problem. Blood. 1998;91(7):2213–2222.
- Working Party of the General Haematology Task Force of the British Committee for Standards in Haematology. The laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998;101(4):783–792.
- Cao A, Galanello R, Rosatelli MC. Prenatal diagnosis and screening of the haemoglobinopathies. Bailliére’s Clin Haematol. 1998;11(1):215–238.
- Langlois S, Ford JC, Chitayat D, . Carrier screening for thalassemia and hemoglobinopathies in Canada. J Obstet Gynaecol Can. 2008;30(10):950–971.
- Sin SY, Ghosh A, Tang LCH, Chan V. Ten years’ experience of antenatal mean corpuscular volume screening and prenatal diagnosis for thalassaemias in Hong Kong. J Obstet Gynaecol Res. 2000;26(3):230–208.
- Lau YL, Chan LC, Chan AYY, . Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong – implications for population screening. N Engl J Med. 1997;336(18):1298–1301.
- Chan LC, Ma SK, Chan AYY, . Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL? J Clin Pathol. 2001;54(4):317–320.